Oncology investigations are a crucial component of cancer care, used for initial diagnosis, exact staging, treatment planning, and long-term monitoring.
Because cancer can manifest in completely different ways depending on the tissue involved, clinical teams rely on a combination of laboratory, imaging, and tissue-based tests.
Laboratory Investigations
Routine Blood Tests & Biochemical Panels
- Complete Blood Count (CBC): This test measures the key cellular components of your blood, including hemoglobin, total leukocyte (white blood cell) counts, differential counts, and platelets. It is essential for detecting hematological anomalies (like abnormal blast cells in leukemia), assessing anemia of chronic disease, or monitoring treatment-induced cytopenias during active chemotherapy.
- Inflammatory Markers (ESR & CRP): Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) track systemic inflammatory activity in the body.
- Liver Function Tests (LFT): This panel tracks hepatic health by measuring enzymes like AST, ALT, and alkaline phosphatase, alongside bilirubin levels. These profiles help dictate a patient’s eligibility for specific systemic therapies.
- Renal Function Tests (RFT): Assessing parameters like blood urea, creatinine, and serum electrolytes ensures the kidneys are functioning adequately to clear chemotherapy agents safely.
- Metabolic and Protein Profiles: Tests tracking serum calcium, phosphate, serum albumin, total protein, and Lactate Dehydrogenase (LDH) give critical insights into metabolic stability and general nutritional health.
Tumor Markers
Tumor markers are quantitative proteins or biochemical chemicals shed by specific cancer cells directly into the bloodstream.
Examples:
PSA (Prostate-Specific Antigen): Utilized exclusively for prostate cancer monitoring and screening.
CA-125: A primary tracker for ovarian malignancies.
CA 15-3: Highly monitored in breast cancer management.
CA 19-9: An important biomarker for pancreatic and hepatobiliary cancers.
CEA (Carcinoembryonic Antigen): Heavily relied upon to track colorectal and general gastrointestinal adenocarcinomas.
Alpha-Fetoprotein (AFP) & Beta-hCG: Vital indicators used to evaluate liver cancer (hepatocellular carcinoma) and germ cell tumors.
Imaging Investigations
- Plain Radiography (X-ray): Standard chest X-rays and comprehensive skeletal surveys remain valuable frontline tools for the rapid detection of lung lesions and potential bone metastases.
- Ultrasonography (USG): Utilizing high-frequency sound waves, ultrasound safely evaluates soft tissues like the abdomen, pelvis, thyroid, and breast. It is also frequently used to provide real-time guidance for needle biopsy procedures.
- Mammography: A highly specialized, low-dose X-ray technique dedicated specifically to breast cancer screening and early diagnosis.
- Computed Tomography (CT Scan): Providing advanced cross-sectional imaging (typically focused on the chest, abdomen, and pelvis), CT scans are performed with contrast dye to map out exact tumor size, assess regional lymph node involvement, localize tumors, and assist in radiation treatment planning.
- Magnetic Resonance Imaging (MRI): Offering superior soft-tissue contrast, MRI is the gold standard imaging choice for central nervous system tumors (brain and spinal cord), soft tissue sarcomas, musculoskeletal malignancies, and complex pelvic evaluations (such as rectal or prostate cancers).
- Radionuclide Bone Scan: A highly sensitive nuclear imaging study that detects increased osteoblastic activity, pinpointing skeletal metastases commonly associated with advanced breast and prostate cancers.
- Positron Emission Tomography (PET & PET-CT): PET is a functional, metabolic imaging tool that uses a radioactive glucose tracer (FDG) to highlight areas of rapid cell turnover—a key hallmark of malignant cells. Modern PET-CT combines this metabolic data with precise anatomical cross-sections, making it invaluable for whole-body staging, restaging, and assessing tumor recurrence.
Endoscopic Investigations
Endoscopy involves inserting a thin, flexible tube equipped with a camera directly into the body’s natural cavities. This allows specialists to achieve direct visualization of mucosal surfaces, accurately map out suspicious lesions, and perform simultaneous tissue biopsies.
Gastrointestinal Endoscopy: Includes Upper GI Endoscopy (EGD) to evaluate the esophagus and stomach, alongside Colonoscopy and Sigmoidoscopy for lower gastrointestinal tract assessments.
Respiratory Endoscopy (Bronchoscopy): Allows direct evaluation of central airway lesions and is often paired with Endobronchial Ultrasound (EBUS) to sample mediastinal lymph nodes.
Genitourinary Endoscopy (Cystoscopy): Provides a clear view inside the urinary bladder and urethra.
Gynecological Endoscopy (Hysteroscopy): Used to inspect the inner lining of the uterus.
Head and Neck Endoscopy: Includes Laryngoscopy and Nasopharyngoscopy to clearly view the pharynx, larynx, and vocal structures.
Cytological & Pathological Investigations
Cytology focuses on the examination of individual, free-floating cells rather than intact tissue architectures.
- Fine Needle Aspiration Cytology (FNAC): A minimally invasive procedure using a very thin needle to draw fluid or cells out of a palpable lump, commonly utilized for breast lumps, thyroid nodules, or accessible lymph nodes.
- Exfoliative Cytology: Examining shed cells via fluid collections, such as sputum cytology, urine cytology, or a standard Pap Smear used for cervical cancer screening.
Histopathological Investigations
Histopathology involves examining intact pieces of tissue to observe how cells are structured in relation to one another, confirming the formal diagnosis while determining the precise tumor type and grade.
Biopsy Techniques: Depending on the location, tissue can be gathered via Incisional Biopsy (removing a small piece), Excisional Biopsy (removing the entire lump), Core Needle Biopsy (extracting a small cylinder of tissue), Punch Biopsy (common in dermatology), or an Endoscopic Biopsy.
Advanced Molecular & Genetic Investigations (Precision Oncology)
Modern oncology relies heavily on personalizing treatment based on the genetic blueprint of the tumor itself.
Immunohistochemistry (IHC): Pathologists apply highly specific antibody stains to the tissue sample to identify tumor-specific proteins and receptor statuses. In breast cancer, for example, IHC tracks Estrogen Receptors (ER), Progesterone Receptors (PR), HER2 status, and cellular proliferation markers like Ki-67 to dictate optimal hormone or targeted therapies.
Molecular Testing (PCR, FISH, & NGS): Advanced laboratory techniques like Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), and Next-Generation Sequencing (NGS) map out precise genetic mutations within the cancer cells. This lets oncology teams select highly specific targeted therapies and predict individual prognoses with incredible accuracy.
Bone Marrow Investigations
Bone Marrow Aspiration & Biopsy: This two-part procedure removes a liquid marrow sample (aspiration) and a small, solid core of surrounding bone tissue (biopsy). This is critical for diagnosing, staging, and tracking leukemia, lymphoma, and multiple myeloma.
Why This Matters for Oncology Physiotherapy
As oncology physiotherapists, this comprehensive diagnostic roadmap directly shapes our specialized rehabilitation protocols. Knowing the results of these investigations helps us anticipate specific physiological limitations:
- An MRI showing spinal lesions alerts us to strict movement precautions to prevent cord compression.
- Fluctuations in a CBC panel tell us when to temporarily modify exercise intensity due to low hemoglobin or low platelets.
- Lymph node assessment and surgical staging help us identify precisely who requires proactive lymphedema management.
Understanding the complex world of oncology investigations ensures that specialized exercise, movement restoration, and physical rehabilitation are delivered with maximum safety, precision, and clinical efficacy.
